Bortezomib in the Treatment of Acquired Von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance

Kansas Journal of Medicine
doi 10.17161/kjm.v7i4.11507
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The University of Kansas

Related search

Monoclonal Gammopathy of Undetermined Significance

English

Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance

Clinical Cancer Research
Cancer ResearchOncology
2009English

Secondary Monoclonal Gammopathy of Undetermined Significance After Allogeneic Stem Cell Transplantation in Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America
OncologyHematology
2007English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Gamma-Heavy Chain Monoclonal Gammopathy With Undetermined Significance (MGUS)

Journal of clinical and experimental hematopathology : JCEH
Medicine
2019English

Prostate Cancer Leading to Monoclonal Gammopathy of Undetermined Significance: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

FOXP1 Expression in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Pathology International
MedicineForensic MedicinePathology
2009English

Is Curcumin for Monoclonal Gammopathy of Undetermined Significance Without Risk? - Letter

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy